What is the role of autoimmunity in multiple sclerosis?

被引:0
|
作者
Chabas, D [1 ]
Liblau, R
机构
[1] Grp Hosp Pitie Salpetriere, Federat Neurol, F-75634 Paris, France
[2] Grp Hosp Pitie Salpetriere, Lab Immunol Cellulaire, F-75013 Paris, France
[3] Grp Hosp Pitie Salpetriere, INSERM, CJF 97 11, F-75013 Paris, France
来源
PATHOLOGIE BIOLOGIE | 2000年 / 48卷 / 01期
关键词
autoimmunity; immunosuppressant; multiple sclerosis;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A number of evidences indicate that an antigen-specific immune reaction is responsible for the formation and/or the maintenance of multiple sclerosis (MS) lesions. This disease is characterized by the following: 1), an infiltration of the white matter of the brain and spinal cord by inflammatory cells; 2), the T and B lymphocytes, present in the lesions or in the cerebrospinal fluid of patients, show signs of activation; i.e., the classic IgG oligoclonal bands of the cerebrospinal fluid (activation of B lymphocytes) and the presence of activation markers on the surface of the T lymphocytes; 3), the presence of an association, and a linkage between the disease and the genes of the HLA complex. The HLA molecules are implicated in the presentation of the antigen to the T lymphocytes; 4), finally, A should be noted that the therapeutic approaches aimed at reducing (immunosuppressants) or at modulating (beta-interferon, copolymer 1) the immune responses have a positive effect on this disease, whereas those treatments which activate the immune system (gamma-interferon) have a negative effect. (C) Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:25 / 46
页数:22
相关论文
共 50 条
  • [21] Sirtuins in Multiple Sclerosis: The crossroad of neurodegeneration, autoimmunity and metabolism
    Foolad, Forough
    Khodagholi, Fariba
    Javan, Mohammad
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 34 : 47 - 58
  • [22] A Systematic Review of the Impact of Dietary Sodium on Autoimmunity and Inflammation Related to Multiple Sclerosis
    Probst, Yasmine
    Mowbray, Erin
    Svensen, Erika
    Thompson, Keats
    ADVANCES IN NUTRITION, 2019, 10 (05) : 902 - 910
  • [23] Vaccination and autoimmunity: influenza vaccination and association with multiple sclerosis
    Maslovaric, Irina
    Stojkovic, Aleksandra
    Kosanovic, Dejana
    Markovic, Dragana
    Ilic, Vesna
    Jovanova-Nesic, Katica
    VOJNOSANITETSKI PREGLED, 2018, 75 (07) : 721 - 729
  • [24] No evidence of pancreatic autoimmunity among patients with multiple sclerosis
    Bilbao, JR
    Villoslada, P
    Martin-Pagola, A
    Castaño, L
    IMMUNOLOGY OF DIABETES III, 2004, 1037 : 133 - 137
  • [25] Lipids at the Cross-road of Autoimmunity in Multiple Sclerosis
    Reale, Marcella
    Sanchez-Ramon, Silvia
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (02) : 176 - 192
  • [26] Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations
    Devonshire, Virginia
    Phillips, Richard
    Wass, Hilary
    Da Roza, Gerald
    Senior, Peter
    JOURNAL OF NEUROLOGY, 2018, 265 (11) : 2494 - 2505
  • [27] Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations
    Virginia Devonshire
    Richard Phillips
    Hilary Wass
    Gerald Da Roza
    Peter Senior
    Journal of Neurology, 2018, 265 : 2494 - 2505
  • [28] Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy
    Jin Nakahara
    Michiko Maeda
    Sadakazu Aiso
    Norihiro Suzuki
    Clinical Reviews in Allergy & Immunology, 2012, 42 : 26 - 34
  • [29] What do we know about the role of lncRNAs in multiple sclerosis?
    Nociti, Viviana
    Santoro, Massimo
    NEURAL REGENERATION RESEARCH, 2021, 16 (09) : 1715 - 1722
  • [30] Subcortical grey matter structures in multiple sclerosis: what is their role in cognition?
    Cruz-Gomez, Alvaro J.
    Aguirre, Naiara
    Sanchis-Segura, Carla
    Avila, Cesar
    Forn, Cristina
    NEUROREPORT, 2018, 29 (07) : 547 - 552